Bank Hapoalim Bm Pfizer Inc Transaction History

Bank Hapoalim Bm

$660 Million
Q3 2024

A detailed history of Bank Hapoalim Bm transactions in Pfizer Inc stock. As of the latest transaction made, Bank Hapoalim Bm holds 130,218 shares of PFE stock, worth $3.41 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares

130,218

Previous 127,317 2.28%

Holding current value

$3.41 Million

Previous $3.56 Million 5.81%

% of portfolio

0.57%

Previous 0.5%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	BUY	$27.7 - $31.39 $80,357 - $91,062	2,901 Added 2.28%	130,218 $3.77 Million
Q2 2024 Jul 23, 2024	SELL	$25.26 - $29.6 $65,221 - $76,427	-2,582 Reduced 1.99%	127,317 $3.56 Million
Q1 2024 May 01, 2024	BUY	$25.89 - $29.73 $2.77 Million - $3.19 Million	107,148 Added 470.96%	129,899 $3.61 Million
Q4 2023 Jan 22, 2024	SELL	$26.13 - $33.94 $224,169 - $291,171	-8,579 Reduced 27.38%	22,751 $655,000
Q3 2023 Oct 24, 2023	SELL	$32.09 - $37.51 $1.05 Million - $1.23 Million	-32,796 Reduced 51.14%	31,330 $1.04 Million
Q2 2023 Jul 26, 2023	SELL	$36.12 - $41.79 $984,053 - $1.14 Million	-27,244 Reduced 29.82%	64,126 $2.35 Million
Q1 2023 Apr 25, 2023	SELL	$39.39 - $51.28 $1.79 Million - $2.32 Million	-45,332 Reduced 33.16%	91,370 $3.73 Million
Q4 2022 Jan 26, 2023	SELL	$41.75 - $54.5 $101,035 - $131,890	-2,420 Reduced 1.74%	136,702 $7.01 Million
Q3 2022 Nov 08, 2022	SELL	$43.76 - $53.42 $2.94 Million - $3.59 Million	-67,210 Reduced 32.57%	139,122 $6.09 Million
Q2 2022 Jul 27, 2022	SELL	$46.53 - $55.17 $464,974 - $551,313	-9,993 Reduced 4.62%	206,332 $10.8 Million
Q1 2022 Apr 28, 2022	SELL	$45.75 - $56.69 $476,715 - $590,709	-10,420 Reduced 4.6%	216,325 $11.2 Million
Q4 2021 Feb 04, 2022	BUY	$41.32 - $61.25 $755,494 - $1.12 Million	18,284 Added 8.77%	226,745 $13.4 Million
Q3 2021 Oct 27, 2021	BUY	$39.25 - $50.42 $5.52 Million - $7.09 Million	140,673 Added 207.52%	208,461 $8.97 Million
Q2 2021 Aug 05, 2021	SELL	$35.91 - $40.68 $346,028 - $391,992	-9,636 Reduced 12.45%	67,788 $2.66 Million
Q1 2021 Apr 26, 2021	SELL	$33.49 - $37.77 $1.4 Million - $1.58 Million	-41,771 Reduced 35.04%	77,424 $2.81 Million
Q4 2020 Feb 03, 2021	BUY	$33.47 - $42.56 $2.02 Million - $2.57 Million	60,452 Added 102.91%	119,195 $4.39 Million
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $103,187 - $121,062	3,250 Added 5.86%	58,743 $2.16 Million
Q2 2020 Aug 04, 2020	SELL	$30.12 - $36.54 $424,089 - $514,483	-14,080 Reduced 20.24%	55,493 $1.82 Million
Q1 2020 May 06, 2020	SELL	$27.03 - $38.62 $160,963 - $229,982	-5,955 Reduced 7.88%	69,573 $2.27 Million
Q4 2019 Feb 03, 2020	SELL	$32.92 - $37.36 $140,733 - $159,714	-4,275 Reduced 5.36%	75,528 $2.96 Million
Q3 2019 Nov 01, 2019	BUY	$32.49 - $42.13 $10,591 - $13,734	326 Added 0.41%	79,803 $2.89 Million
Q2 2019 Aug 06, 2019	BUY	$36.98 - $41.52 $474,823 - $533,116	12,840 Added 19.27%	79,477 $3.44 Million
Q1 2019 May 07, 2019	BUY	$37.5 - $41.2 $153,450 - $168,590	4,092 Added 6.54%	66,637 $2.83 Million
Q4 2018 Feb 11, 2019	SELL	$38.47 - $43.86 $403,050 - $459,521	-10,477 Reduced 14.35%	62,545 $2.73 Million
Q3 2018 Nov 08, 2018	BUY	$34.47 - $41.81 $7,066 - $8,571	205 Added 0.28%	73,022 $3.22 Million
Q2 2018 Jul 24, 2018	BUY	$32.98 - $35.16 $6,826 - $7,278	207 Added 0.29%	72,817 $2.64 Million
Q1 2018 Apr 30, 2018	SELL	$31.91 - $37.02 $829,021 - $961,779	-25,980 Reduced 26.35%	72,610 $2.58 Million
Q4 2017 Feb 05, 2018	SELL	$33.26 - $35.29 $437,335 - $464,028	-13,149 Reduced 11.77%	98,590 $0
Q3 2017 Nov 07, 2017	SELL	$31.0 - $34.15 $276,737 - $304,857	-8,927 Reduced 7.4%	111,739 $3.99 Million
Q2 2017 Aug 11, 2017	BUY	N/A	120,666	120,666 $4.05 Million

Others Institutions Holding PFE

# of Institutions

3,258

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Hapoalim Bm, based on Form 13F filings with the SEC.

News

Stay updated on Bank Hapoalim Bm with notifications on news.

Account